Papers by Yibing Lu
9 results
- Diabetes Therapy
Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)
Trial in 306 peopleSurvodutide - The Lancet Diabetes & Endocrinology
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
Randomised trial in 242 peopleSemaglutide
- ADA Scientific Sessions 2026 Abstract
Efsubaglutide Alfa in Overweight or Obesity: Phase 2b ENLIGHT Study
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Dual GLP-1/GIP Receptor Agonist HDM1005 in Obese Participants without Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of Tirzepatide Added to Basal Insulin in Chinese Patients with Type 2 Diabetes (SURPASS-CN-INS)
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist in Participants with Type 2 Diabetes Mellitus Up to 32 Weeks
Trial in peopleInterventions